Efficacy, Safety and Immunogenicity of Enerceptan Compared to Enbrel in Rheumatoid Arthritis
Clinical trial NCT03332719 · COMPLETED
Trial details
- NCT number
- NCT03332719
- Sponsor
- Gema Biotech S.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2017-03-01
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.